SERA PROGNOSTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Utah
This Employment Agreement (this “Agreement”) is effective for all purposes as of May 15, 2017 (the “Effective Date”), by and between Sera Prognostics, Inc., a Delaware corporation (the “Company”), and Nadia Altomare (the “Employee”).
ContractWarrant Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Delaware
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
SECOND AMENDMENT TO COMMERCIALIZATION AGREEMENTCommercialization Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
THIS Second Amendment to the January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively as “Parties.”
June 19, 2020Separation Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Utah
COMMERCIAL COLLABORATION AGREEMENTCommercial Collaboration Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • New York
This Commercial Collaboration Agreement (this “Agreement”), dated as of February 17, 2021 (the “Effective Date”), is made by and between Anthem, Inc. and its Affiliates (as defined below) (collectively, “Anthem”) on the one hand, and Sera Prognostics, Inc. (“Company”) on the other hand.
COMMERCIALIZATION AGREEMENTCommercialization Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Delaware
This Commercialization Agreement (“Agreement”) is effective as of January 9, 2017 (“Effective Date”) and is entered into by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”
First Amendment to Commercialization AgreementCommercialization Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
This First Amendment to Commercialization Agreement (“Amendment”) is made and shall be effective upon the date this Amendment is signed by both Parties (“Amendment Date”) by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”
